Syschem (India) Ltd has started commercial production at its new Haryana units, including an expanded Amoxicillin facility (1,200 MT) and a new Cloxacillin unit (600 MT). The expansion boosts manufacturing capacity, strengthens its pharma portfolio, and positions the company for growth in both domestic and international antibiotic markets.
Show moreStay Ahead – Explore Now! NHPC Board To Consider Rs 2,000 Crore Bond Issue
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
